Abstract:Immune-based therapeutic approaches for IBD, including anti-TNF therapy, have shown significant success during the last decade. Nevertheless, many patients are not responsive to these therapies and suffer from severe side effects. Therefore, an increased understanding of the fundamental immune mechanisms controlling gut inflammation is critical for the rational design and development of more effective therapies of IBD. Innate lymphoid cells (ILCs) have recently emerged as key players in regulating the balance between protective immunity and immunopathology at mucosal surfaces. However, the cellular and molecular pathways that control crosstalk between ILCs and intestinal epithelial cells during inflammation remain poorly understood. Our recent study revealed that Lymphotoxin (LT), a member of TNF superfamily of cytokines, produced by RORgt+ ILCs in the gut is critical for protection against the mucosal bacterial pathogen Citrobacter rodentium. In the present study, we aimed to determine how LT signaling controls ILCs to regulate the intestinal inflammation. An acute mouse model of IBD induced by dextran sodium sulfate (DSS) was used. WT and LT-beta receptor (LTbR)-deficient mice were treated with 3.5% DSS in drinking water for 5 days followed by normal water thereafter. Our data show that LTbR signaling is essential for protection and recovery from DSS-induced colitis. LTbR deficient mice failed to upregulate IL-22 in the colon and succumbed rapidly after DSS administration. By using RORgt-GFP reporter mice and cell sorting approach we found the impaired IL-22 production by distinct populations of ILCs in the colon after DSS-induced inflammation. Recent studies indicated a protective role of IL-22 in IBD by enhancing barrier integrity and epithelial innate immunity. We found that reduced IL-22 expression in LTbR-deficient mice was associated with defected mucin genes expression and impaired proliferation of intestinal epithelial cells after DSS-induced injury. Bone marrow transfer experiments revealed that LTbR expression on both bone marrow-derived and radioresistant stromal cells is required for the control of intestinal inflammation. To define which LTbR-expressing cells are essential for protection, we have generated mice with a specific inactivation of LTbR in intestinal epithelial cells, and bone marrow-derived cell populations. These mouse models will help us to further investigate the critical pathways to control intestinal inflammation. Our data indicate that LTbR signaling prevents intestinal inflammation by controlling the IL-22 protection pathway.

CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis

Prevention of Experimental Colitis in SCID Mice Reconstituted with CD45RBhigh CD4+ T Cells by Blocking the CD40-CD154 Interactions1

Transcription factor c-Rel plays a crucial role in driving anti-CD40-mediated innate colitis

Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction.

B7 Interactions with CD28 and CTLA-4 Control Tolerance or Induction of Mucosal Inflammation in Chronic Experimental Colitis

A RORγt+ cell instructs gut microbiota-specific Treg cell differentiation

TSLP/dendritic cell axis promotes CD4+ T cell tolerance to the gut microbiome

Dysregulation of CD177+ neutrophils on intraepithelial lymphocytes exacerbates gut inflammation via decreasing microbiota-derived DMF

ILC3s select for RORγt+ Tregs and establish tolerance to intestinal microbiota

IL-10 downregulates CXCR3 expression on Th1 cells and interferes with their migration to intestinal inflammatory sites

CD1d1 Intrinsic Signaling in Macrophages Controls NLRP3 Inflammasome Expression During Inflammation.

T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid Cells

CTLA-4 expressing innate lymphoid cells modulate mucosal homeostasis in a microbiota dependent manner

Lymphotoxin-Dependent Control of Intestinal Inflammation

CD1d-mediated lipid presentation by CD11c+ cells regulates intestinal homeostasis

Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFNγ

Loss of PI3Kδ activity drives autoimmune colitis by impairing extrathymic Treg differentiation

CD30L is involved in the regulation of the inflammatory response through inducing homing and differentiation of monocytes via CCL2/CCR2 axis and NF-κB pathway in mice with colitis

Dominant immune tolerance in the intestinal tract imposed by RelB-dependent migratory dendritic cells regulates protective type 2 immunity

Integrin CD11b Attenuates Colitis by Strengthening Src-Akt Pathway to Polarize Anti-Inflammatory IL-10 Expression